A Phase I Study to Evaluate the Safety and Pharmacokinetics of CT-P41 and EU-approved Prolia in Healthy Male Subjects
PHASE1This study is a Pilot Phase 1, Double-Blind, Randomized, Two-arm, Parallel ...
A Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosis
PHASE3This study is a Double-blind, Randomized, Active-controlled, Phase 3 Study ...
Location
Center For Clinical And Basic Research
Phase I Study to Compare the Pharmacokinetics, Pharmacodynamics, and Safety Between CT-P41 and US-licensed Prolia in Healthy Male Subjects
PHASE1A Randomized, Double-blind, Two-arm, Parallel group, Single-dose, Phase I S...
Location
CHA Bundang Medical Center